• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Long-term results of accelerated corneal collagen crosslinking in paediatric patients with progressive keratoconus: 10-year follow-up.儿童进展性圆锥角膜行加速角膜胶原交联术的 10 年随访结果。
Eye (Lond). 2024 Sep;38(13):2522-2529. doi: 10.1038/s41433-024-03064-7. Epub 2024 Apr 12.
2
Standard and accelerated crosslinking protocols in keratoconus - differences and evolution at one year.圆锥角膜的标准和加速交联方案——一年时的差异与进展
Rom J Ophthalmol. 2025 Apr-Jun;69(2):175-183. doi: 10.22336/rjo.2025.29.
3
Evaluation of refractive, tomographic and biomechanical changes after customized accelerated corneal collagen cross-linking in keratoconus patients: a retrospective observational study.圆锥角膜患者定制加速角膜胶原交联术后屈光、断层扫描及生物力学变化的评估:一项回顾性观察研究。
BMC Ophthalmol. 2025 Jul 1;25(1):378. doi: 10.1186/s12886-025-04195-5.
4
Conventional Epithelial-Off Corneal Crosslinking in Patients With Progressive Keratoconus: 10-Year Outcomes.常规上皮下角膜交联术治疗进展性圆锥角膜:10 年结果。
Cornea. 2024 Jul 1;43(7):874-882. doi: 10.1097/ICO.0000000000003532. Epub 2024 Mar 27.
5
A comparative analysis of the 1-year outcomes of modified Athens protocol versus Cretan protocol in the treatment of progressive keratoconus.改良雅典方案与克里特方案治疗进行性圆锥角膜1年疗效的对比分析
BMC Ophthalmol. 2025 Jul 1;25(1):376. doi: 10.1186/s12886-025-04172-y.
6
Comparative Analysis of Combined Topography-Guided Photorefractive Keratectomy and Corneal Crosslinking in Progressive Versus Stable Keratoconus.进行性与稳定性圆锥角膜中联合地形引导的准分子激光原位角膜磨镶术和角膜交联术的对比分析
Cornea. 2024 Jul 31;44(8):983-991. doi: 10.1097/ICO.0000000000003653.
7
Pulsed corneal crosslinking in the treatment of Keratoconus: a systematic review and meta-analysis.脉冲角膜交联术治疗圆锥角膜:一项系统评价与荟萃分析
Graefes Arch Clin Exp Ophthalmol. 2025 Mar;263(3):589-601. doi: 10.1007/s00417-024-06622-7. Epub 2024 Aug 31.
8
Safety and efficacy of simultaneous photorefractive keratectomy and corneal cross-linking in managing suspected keratoconus.准分子激光原位角膜磨镶术与角膜交联术联合治疗疑似圆锥角膜的安全性和有效性
Indian J Ophthalmol. 2025 Jul 1;73(7):959-965. doi: 10.4103/IJO.IJO_1941_24. Epub 2025 Apr 17.
9
Epithelium-on versus epithelium-off corneal collagen crosslinking for keratoconus: a systematic review and meta-analysis.角膜胶原交联术治疗圆锥角膜的上皮下与上皮内模式:系统评价和荟萃分析。
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1683-1692. doi: 10.1007/s00417-023-06287-8. Epub 2023 Nov 8.
10
Keratometry Changes Between Year One to Seven After Corneal Cross-Linking in Patients With Keratoconus.角膜交联术后一年至七年角膜曲率变化:圆锥角膜患者的研究。
Cornea. 2024 Nov 1;43(11):1397-1402. doi: 10.1097/ICO.0000000000003478. Epub 2024 Jan 30.

引用本文的文献

1
Bilateral simultaneous accelerated corneal collagen cross-linking in pediatric keratoconus: 24-month follow-up results.儿童圆锥角膜双侧同步加速角膜胶原交联:24个月随访结果
Indian J Ophthalmol. 2025 May 1;73(5):769-774. doi: 10.4103/IJO.IJO_1967_24. Epub 2025 Apr 24.

本文引用的文献

1
Corneal Collagen Cross-Linking for Progressive Keratoconus in Pediatric Patients: Up to 14 Years of Follow-up.小儿进行性圆锥角膜的角膜胶原交联术:长达14年的随访
Am J Ophthalmol. 2023 Nov;255:170-177. doi: 10.1016/j.ajo.2023.07.017. Epub 2023 Jul 20.
2
Efficacy, Safety, and Outcomes following Accelerated and Iontophoresis Corneal Crosslinking in Progressive Keratoconus.进行性圆锥角膜加速及离子导入角膜交联术后的疗效、安全性及结果
J Clin Med. 2023 Apr 18;12(8):2931. doi: 10.3390/jcm12082931.
3
Long-term Safety and Efficacy of Corneal Collagen Crosslinking in a Pediatric Group With Progressive Keratoconus: A 7-year Follow-up.儿童进展性圆锥角膜行角膜胶原交联术的 7 年随访:长期安全性和疗效。
Am J Ophthalmol. 2023 Jun;250:59-69. doi: 10.1016/j.ajo.2023.01.012. Epub 2023 Jan 20.
4
Comparison of Efficacy and Safety Between Standard, Accelerated Epithelium-Off and Transepithelial Corneal Collagen Crosslinking in Pediatric Keratoconus: A Meta-Analysis.儿童圆锥角膜标准、快速上皮去除和经上皮角膜胶原交联的疗效与安全性比较:一项荟萃分析
Front Med (Lausanne). 2022 Mar 17;9:787167. doi: 10.3389/fmed.2022.787167. eCollection 2022.
5
Clinical Outcomes of Accelerated Corneal Cross-Linking for Pediatric Keratoconus.儿童圆锥角膜加速角膜交联术的临床结果
J Ophthalmol. 2021 Nov 18;2021:1851883. doi: 10.1155/2021/1851883. eCollection 2021.
6
Corneal Cross-Linking as Treatment in Pediatric Keratoconus: Comparison of Two Protocols.角膜交联术治疗儿童圆锥角膜:两种方案的比较。
J Ophthalmol. 2021 Nov 3;2021:2659828. doi: 10.1155/2021/2659828. eCollection 2021.
7
Accelerated Corneal Collagen Cross-Linking in Pediatric Keratoconus.小儿圆锥角膜的加速角膜胶原交联
J Curr Ophthalmol. 2021 Oct 22;33(3):285-290. doi: 10.4103/joco.joco_163_20. eCollection 2021 Jul-Sep.
8
[Stage-appropriate treatment of keratoconus].圆锥角膜的分期适宜治疗
Ophthalmologe. 2021 Oct;118(10):1069-1088. doi: 10.1007/s00347-021-01410-8. Epub 2021 Jun 28.
9
Long term results of accelerated corneal collagen cross-linking in pediatric keratoconus.加速角膜胶原交联术治疗儿童圆锥角膜的长期疗效。
Eur J Ophthalmol. 2021 Nov;31(6):3494-3499. doi: 10.1177/11206721211018362. Epub 2021 May 20.
10
[Safety and efficiency of epithelium-off accelerated corneal cross-linking for progressive keratoconus in pediatric patients].[上皮去除加速角膜交联术治疗儿童进行性圆锥角膜的安全性和有效性]
J Fr Ophtalmol. 2021 Jun;44(6):828-834. doi: 10.1016/j.jfo.2020.11.012. Epub 2021 Apr 9.

儿童进展性圆锥角膜行加速角膜胶原交联术的 10 年随访结果。

Long-term results of accelerated corneal collagen crosslinking in paediatric patients with progressive keratoconus: 10-year follow-up.

机构信息

University of Health Sciences, Beyoglu Eye Training and Research Hospital, Department of Ophthalmology, Istanbul, Turkey.

出版信息

Eye (Lond). 2024 Sep;38(13):2522-2529. doi: 10.1038/s41433-024-03064-7. Epub 2024 Apr 12.

DOI:10.1038/s41433-024-03064-7
PMID:38609652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11383957/
Abstract

OBJECTIVES

To evaluate the 10-year visual, refractive, and tomographic outcomes of epithelium-off accelerated corneal collagen cross-linking (ACCL) in paediatric patients with progressive keratoconus (KC) and to compare the stages in terms of re-progression.

METHODS

Patients under 18 years of age with progressive KC who underwent ACCL between 2010 and 2012 and completed at least 10 years of follow-up were included in this retrospective study. Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), refractive errors, and corneal tomography parameters were evaluated preoperatively and at 1, 5, and 10 years postoperatively. The effect of stage and age on re-progression was analysed.

RESULTS

The study included 175 eyes of 97 patients (mean age: 14.46 ± 2.17 years). Improvement in UDVA and CDVA was observed in all postoperative periods compared to the preoperative period (each p-value < 0.05). The increase in spherical equivalent (SE), flattening of keratometry values, and decrease in thinnest corneal thickness (TCT) were statistically significant in the tenth year compared to preoperatively (each p-value < 0.05). Re-progression was observed in 16 eyes (9.14%). Haze was observed in 13 eyes (7.43%), 4 of which were permanent. Deep anterior lamellar keratoplasty was performed in 3 eyes (1.7%) and a second ACCL in 3 eyes (1.7%).

CONCLUSIONS

ACCL is an effective and safe long-term strategy to prevent progression of KC in paediatric patients. In the light of this study with a 10-year follow-up re-progression rate of 9.14%, long-term follow-up of patients after ACCL for possible re-progression and the need for re-CCL or keratoplasty may be recommended.

摘要

目的

评估上皮下加速角膜胶原交联(ACCL)治疗进展性圆锥角膜(KC)儿童患者的 10 年视力、屈光和断层成像结果,并比较进展程度的再进展情况。

方法

本回顾性研究纳入了 2010 年至 2012 年间接受 ACCL 治疗且至少随访 10 年的年龄在 18 岁以下、进展性 KC 患者。在术前和术后 1、5 和 10 年分别评估未矫正远视力(UDVA)、矫正远视力(CDVA)、屈光不正和角膜断层参数。分析了阶段和年龄对再进展的影响。

结果

该研究共纳入了 97 例患者的 175 只眼(平均年龄:14.46±2.17 岁)。与术前相比,所有术后期间 UDVA 和 CDVA 均有所改善(p 值均<0.05)。与术前相比,第 10 年时球镜等效(SE)增加、角膜曲率值变平、最薄角膜厚度(TCT)减少,差异有统计学意义(p 值均<0.05)。16 只眼(9.14%)出现再进展。13 只眼(7.43%)出现混浊,其中 4 只为永久性混浊。3 只眼(1.7%)行深板层角膜移植术,3 只眼(1.7%)行二次 ACCL。

结论

ACCL 是预防儿童患者 KC 进展的一种有效且安全的长期策略。根据本研究 10 年随访的再进展率为 9.14%,建议对接受 ACCL 治疗的患者进行长期随访,以预防可能的再进展,并考虑再次行 CCL 或角膜移植术的必要性。